Aspergillosis Pneumonia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Aspergillosis Pneumonia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT03748069

Influenza Associated Aspergillosis In-depth Investigation

This trial is aimed to study the immunological and pathological characteristics of influenza versus non-influenza severe community-acquired pneumonia patients i…

Belgium45 participantsStarted 2019-01-18

All recent trials (18 shown)

Active — Not RecruitingNot Applicable

NCT04530799

Prospective Observational Trial of IAPA

A prospective multi-center observational study to assess the incidence of influenza-associated pulmonary aspergillosis (IAPA) in ICU patients and to identify ho…

Belgium, France350 participantsStarted 2022-03-10

Treatment: Identification of biomarkers for IAPA via patient sampling

Active — Not RecruitingNot Applicable

NCT07238114

Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors

Invasive pulmonary aspergillosis (IPA) is a life-threatening fungal infection of the respiratory system, caused by a specific fungus called Aspergillus species.…

Belgium450 participantsStarted 2025-08-01

Aspergillosis Pneumonia

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Influenza Associated Aspergillosis In-depth Investigation

All recent trials (18 shown)

Prospective Observational Trial of IAPA

Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Influenza Associated Aspergillosis In-depth Investigation

All recent trials (18 shown)

Prospective Observational Trial of IAPA

Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors

COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI)

Pharmacokinetics of Voriconazole in Adult ECMO Patients

Incidence of Invasive Pulmonary Aspergillosis in Ventilator-associated Pneumonia

Performance Evaluation of the Fujifilm Wako Beta-D-glucan Technique in the Diagnosis of Major Invasive Fungal Infections…

Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds

Bronchoalveolar Lavage Combined With High-throughput Sequencing Technology

Prospective Observational Study on the Incidence of Opportunistic Fungal Infections

Assessing Diagnostic Methods for Invasive Fungal Disease in Lung Transplant Recipients

Non-invasive Diagnosis of Invasive Pulmonary Aspergillosis by Use of Biomarkers in Exhaled Breath Condensate

Non-invasive Tools to Diagnose Invasive Aspergillosis Infections in ICU Patients With COVID-19 and Other Conditions.

Mucormycosis in COVID-19

COVID-19 and VA-LRTI: Second Versus First Wave of the Pandemic

Invasive Pulmonary Aspergillosis Complicating Influenza Infection

Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU

Diagnosis of Lung Complication After Allo-HSCT by Multiple Parameter System Through BAL